Treace Medical Concepts (TMCI) EBITDA Margin (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Treace Medical Concepts | 234.79 Mn | 182.94 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,322.00 |
| Dec 31, 2025 | 1,733.00 |
| Sep 30, 2025 | 436.00 |
| Jun 30, 2025 | -637.00 |
| Mar 31, 2025 | -2,950.00 |
| Dec 31, 2024 | 3,272.00 |
| Sep 30, 2024 | 1,433.00 |
| Jun 30, 2024 | -1,119.00 |
| Mar 31, 2024 | -2,713.00 |
| Dec 31, 2023 | 3,322.00 |
| Sep 30, 2023 | -1,318.00 |
| Jun 30, 2023 | 232.00 |
| Mar 31, 2023 | -2,303.00 |
| Dec 31, 2022 | 2,779.00 |
| Sep 30, 2022 | 2,080.00 |
| Jun 30, 2022 | -2,640.00 |
| Mar 31, 2022 | -1,437.00 |
| Dec 31, 2021 | 852.00 |
| Sep 30, 2021 | -564.00 |
| Jun 30, 2021 | -1,212.00 |
| Mar 31, 2021 | -2,257.00 |
| Dec 31, 2020 | 1,552.00 |
| Sep 30, 2020 | 1,917.00 |
| Jun 30, 2020 | -896.00 |